Clinical Trial Update: A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis [NA]

View source ↗

Summary

A pilot study of lenalidomide, melphalan, and dexamethasone in AL amyloidosis has completed, with results posted in March 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• Alkeran (melphalan)
• Decadron (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Stanford University | Conditions: Leukemia, Amyloidosis | NA | Status: COMPLETED | Results posted: 2017-03-22